業績
四半期
財務
CF
資本
配当
住友化学
Remeasurements Of Defined Benefit Plans、投資有価証券売却益、Increase In Property Plant And Equipment And Intangible Assets - Pharmaceuticals Reportable Segments Member他2件
#
#グラフ
#追加
#Top
4005 住友化学
4005
2024/10/31
時価
6794億円
PER
予
26.84倍
2010年以降
赤字
-137.94倍
(2010-2024年)
PBR
0.74倍
2010年以降
0.46-1.77倍
(2010-2024年)
配当
予
2.2%
ROE
予
2.75%
ROA
予
0.67%
資料
有報
大量
適時
Link
IR
決算
業績
四半期
価値
CSV,JSON
Y!
株探
みん株
Remeasurements Of Defined Benefit Plans、投資有価証券売却益、Increase In Property Plant And Equipment And Intangible Assets - Pharmaceuticals Reportable Segments Member他2件
【期間】
1Q
2Q
3Q
通期
全期間
年度
Remeasurements Of Defined Benefit Plans
投資有価証券売却益
Increase In Property Plant And Equipment And Intangible Assets - Pharmaceuticals Reportable Segments Member
Leasehold Right
Dividends From SurplusREBF
2015/06
-
60.1億
-
-
-
2017/06
-
34.1億
-43.1%
-
-
-
2015年6月
Remeasurements Of Defined Benefit Plans
-
投資有価証券売却益
60億500万
Increase In Property Plant And Equipment And Intangible Assets - Pharmaceuticals Reportable Segments Member
-
Leasehold Right
-
Dividends From SurplusREBF
-
2017年6月
Remeasurements Of Defined Benefit Plans
-
投資有価証券売却益
34億1400万
Increase In Property Plant And Equipment And Intangible Assets - Pharmaceuticals Reportable Segments Member
-
Leasehold Right
-
Dividends From SurplusREBF
-